News
Elevation Oncology, which spent the spring fending off activist investor demands to wind down, has become the latest ...
After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious disease R&D for the British pharma. | After nearly 25 years with Sanofi, Sanjay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback